# VNRX-5024 Safety and PK in Healthy Adult Volunteers

> **NCT04314206** · PHASE1 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 36 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** VNRX-5024
- **DRUG:** Placebo for VNRX-5024

## Key facts

- **NCT ID:** NCT04314206
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-27
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04314206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04314206, "VNRX-5024 Safety and PK in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04314206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*